Bulletin
Investor Alert

New York Markets Open in:

Sept. 4, 2020, 8:52 a.m. EDT

The Dow Jones Index – The Story of COVID-19 Winners

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Amazon.com Inc. (AMZN)
  • X
    Apple Inc. (AAPL)
  • X
    Microsoft Corp. (MSFT)

or Cancel Already have a watchlist? Log In

Sep 04, 2020 (IAM Newswire via COMTEX) -- Despite not including electrifying stocks such as Amazon /zigman2/quotes/210331248/composite AMZN +0.08% and therefore missing out on its historical gains, The Dow Jones index still has quite a few winners under its umbrella. Although Apple /zigman2/quotes/202934861/composite AAPL +0.0087% and Microsoft /zigman2/quotes/207732364/composite MSFT -2.84% had their worst performing days since March yesterday, the drop was followed by their peers Facebook /zigman2/quotes/205064656/composite FB -2.70% , Alphabet /zigman2/quotes/205453964/composite GOOG -3.08% and Amazon. One bad day cannot erase the massive rally of these tech stocks which literally bloomed throughout the pandemic, or more precisely, the first two quarters of the year.

Apple shares rose nearly 70% to date with the market value surpassing $2 trillion market cap. Moreover, Apple is no longer dependent on its 'sacred cash cow', iPhone, as it showed it is successfully reshaping its business model to services. But even the iPhone is doing well, as Omdia’s research showed that iPhone 11 was the most popular smartphone during the first half of 2020.

Microsoft latest revenue of $38 billion exceeded expectations of $35.5 billion. Earnings per share of $1.46 exceeded the estimate of $1.36. If we look at Intelligent Cloud alone, revenue amounted to $13.4 billion. The story of Microsoft's rebirth is greatly owed to its Intelligent Cloud business. During the fourth quarter, Intelligent Cloud brough in a revenue of $13.4 billion. This a 17% increase compared to the same quarter last year. If the pandemic has showed us anything is that tech is crucial for business resilience and faster recovery. Coca Cola Company /zigman2/quotes/209159848/composite KO -1.43% and Walgreens Boots /zigman2/quotes/203410933/composite WBA -2.18% also turned to Microsoft for its simplicity and seamless integration.

Microsoft's gaming business also saw skyrocketing growth of 64%, amounting to 1.3 billion, as Xbox hardware revenue jumped 49%. The Xbox Series X is also coming in November. Microsoft has over a billion enterprise users and it can be found in nearly every enterprise of the planet. From early March to the end of April, Microsoft Teams grew from 11 million to over 75 million users. Users want systems that can work together without complexity and Microsoft delivered on that promise.

Although Astrazeneca /zigman2/quotes/200304487/composite AZN +2.06% is the leader in the vaccine race, Johnson and Johnson /zigman2/quotes/201724570/composite JNJ -0.87% has ample financial resources along with an array of brands to boost its chances. Yesterday, Reuters reported that Johnson & Johnson announced its coronavirus vaccine prevented hamsters from getting severely ill. Although we need to wait for human trails to begin next month, this is something to be excited about. Its pharmaceutical segment still stood strong amid the devastating second quarter. Despite falling earnings, the company continued to pay dividends. Johnson and Johnson is a Dividend Aristocrat, a company that not only continuously pay dividends, but also keeps increasing them. The bottom line is that it is diversified enough to survive the storm while also expecting to expand earnings for fiscal 2020 despite delivering losses in the second quarter.

Despite the focus on performance chemicals, Dow Chemical /zigman2/quotes/203121064/composite DOW -2.84% portfolio is actually quite diversified. During the second quarter, some of Dow’s sales did suffer as it was the worst quarter of the year all over the globe. But despite plummeting sales of big items such as new homes, furniture, and cars, sales of cleaning and disinfecting products, which also use Dow’s chemicals, increased. People started cooking at home, increasing the demand for food packaging. Professional construction chemical sales dropped, but do-it-yourself home improvement rose and pulled paints and coatings along. This diversified portfolio allowed Dow to outperform expectations. More importantly, it generated plenty of cash to fund its dividend.

Pharma titan Merck /zigman2/quotes/209956077/composite MRK -1.24% and recently expelled from the Dow, Pfizer /zigman2/quotes/202877789/composite PFE -0.68% , appear to be two of the most evenly matched competitors in the pharmaceutical sector. But unlike Merck, Pfizer is limping besides the pandemic creating an opportunity for a vaccine. Merck also has two vaccine candidates. Chief executive Kenneth Frazier announced on Thursday that human testing is starting fairly soon. Over the last half of a decade, Merck’s stock has consistently outperformed Pfizer’s. Merck's value grew by 6% whereas Pfizer’s dropped 3.1%.

Over the next three years, Merck will invest $19 billion into expanding its oncology, vaccine, and animal health segments. Its cancer immunotherapy is expected to continue fueling its sales as Keytruda sales were 46% year over year.

The Procter & Gamble Company /zigman2/quotes/202894679/composite PG -0.76% had its best fiscal year in more than a decade. Despite all of us being germ-conscious in this new pandemic era, we still have cravings such as donut and coffee. Procter & Gamble has already teamed up with Dunkin’ Brands Group, Inc. /zigman2/quotes/200947441/composite DNKN +16.12% -owned Dunkin’ Donuts to promote the use of its cleaning products in restaurants, but it is looking for more partners with fast-food, hospitality, transportation and healthcare companies. At the end of the day, it's more than revenue- it's free publicity. Sales gains managed to beat management’s target for the fourth consecutive quarter, and cash flow and profitability reached new highs. But most importantly, the outlook is even brighter with further market share expansion. Fiscal 2020 results are evidence that P&G can invest aggressively in growth strategies while still boosting profitability.

So, there you have it. Big Tech, medical devices, pharmaceutical and consumer goods Dow winners of the pandemic. And there's no reason to doubt that post-COVID era will be just as kind to them as they provided meaningful service and products that actually made a difference during these unprecedented circumstances.

This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure . IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you're interested in becoming an IAM journalist contact: contributors@iamnewswire.com

The post The Dow Jones Index – The Story of COVID-19 Winners appeared first on IAM Newswire .

COMTEX_370703764/2618/2020-09-04T08:51:51

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/210331248/composite
US : U.S.: Nasdaq
$ 3,207.04
+2.64 +0.08%
Volume: 5.90M
Oct. 26, 2020 4:00p
P/E Ratio
123.27
Dividend Yield
N/A
Market Cap
$1605.05 billion
Rev. per Employee
$359,671
loading...
/zigman2/quotes/202934861/composite
US : U.S.: Nasdaq
$ 115.05
+0.01 +0.0087%
Volume: 111.85M
Oct. 26, 2020 4:00p
P/E Ratio
34.98
Dividend Yield
0.71%
Market Cap
$1994.49 billion
Rev. per Employee
$1.98M
loading...
/zigman2/quotes/207732364/composite
US : U.S.: Nasdaq
$ 210.08
-6.15 -2.84%
Volume: 37.11M
Oct. 26, 2020 4:00p
P/E Ratio
36.47
Dividend Yield
1.07%
Market Cap
$1635.31 billion
Rev. per Employee
$902,473
loading...
/zigman2/quotes/205064656/composite
US : U.S.: Nasdaq
$ 277.11
-7.68 -2.70%
Volume: 21.32M
Oct. 26, 2020 4:00p
P/E Ratio
33.85
Dividend Yield
N/A
Market Cap
$811.31 billion
Rev. per Employee
$1.57M
loading...
/zigman2/quotes/205453964/composite
US : U.S.: Nasdaq
$ 1,590.45
-50.55 -3.08%
Volume: 1.85M
Oct. 26, 2020 4:00p
P/E Ratio
35.47
Dividend Yield
N/A
Market Cap
$1113.37 billion
Rev. per Employee
$1.39M
loading...
/zigman2/quotes/209159848/composite
US : U.S.: NYSE
$ 49.80
-0.72 -1.43%
Volume: 14.70M
Oct. 26, 2020 4:00p
P/E Ratio
25.83
Dividend Yield
3.29%
Market Cap
$217.11 billion
Rev. per Employee
$506,342
loading...
/zigman2/quotes/203410933/composite
US : U.S.: Nasdaq
$ 37.21
-0.83 -2.18%
Volume: 7.69M
Oct. 26, 2020 4:00p
P/E Ratio
75.32
Dividend Yield
5.03%
Market Cap
$32.94 billion
Rev. per Employee
$380,198
loading...
/zigman2/quotes/200304487/composite
US : U.S.: Nasdaq
$ 53.07
+1.07 +2.06%
Volume: 6.02M
Oct. 26, 2020 4:00p
P/E Ratio
64.72
Dividend Yield
2.58%
Market Cap
$135.95 billion
Rev. per Employee
$342,432
loading...
/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 143.97
-1.27 -0.87%
Volume: 6.93M
Oct. 26, 2020 4:00p
P/E Ratio
22.62
Dividend Yield
2.81%
Market Cap
$382.39 billion
Rev. per Employee
$603,509
loading...
/zigman2/quotes/203121064/composite
US : U.S.: NYSE
$ 47.15
-1.38 -2.84%
Volume: 4.03M
Oct. 26, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
5.94%
Market Cap
$35.97 billion
Rev. per Employee
N/A
loading...
/zigman2/quotes/209956077/composite
US : U.S.: NYSE
$ 78.84
-0.99 -1.24%
Volume: 8.70M
Oct. 26, 2020 4:02p
P/E Ratio
19.19
Dividend Yield
3.09%
Market Cap
$201.91 billion
Rev. per Employee
$615,159
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 37.92
-0.26 -0.68%
Volume: 32.05M
Oct. 26, 2020 4:02p
P/E Ratio
15.08
Dividend Yield
4.01%
Market Cap
$212.16 billion
Rev. per Employee
$580,595
loading...
/zigman2/quotes/202894679/composite
US : U.S.: NYSE
$ 141.30
-1.08 -0.76%
Volume: 5.32M
Oct. 26, 2020 4:02p
P/E Ratio
27.01
Dividend Yield
2.24%
Market Cap
$353.05 billion
Rev. per Employee
$727,304
loading...
/zigman2/quotes/200947441/composite
US : U.S.: Nasdaq
$ 103.10
+14.31 +16.12%
Volume: 14.86M
Oct. 26, 2020 4:00p
P/E Ratio
39.35
Dividend Yield
1.56%
Market Cap
$7.31 billion
Rev. per Employee
$1.19M
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.